assay was developed to test dialysates for inhibitory action against protein synthesis.
In our study, fractions obtained from hemodialysates of uremic patients were tested for their effect on protein synthesis. The in vitro incorporation of tritiated leucine into protein by rat liver homogenates was the model system chosen. This in vitro assay was selected because it allowed the study of the small amounts of materials that were obtained from fractions of hemodialysate.
MATERIALS AND METHODS
Hemodialysis fluid was obtained during the treatment of uremic patients on the twin coil, disposable artificial kidney. The patients studied had uremia manifested by azotemia and central nervous system signs and symptoms related to the uremia. Five patients studied required treatment with hemodialysis to keep them alive. Two were treated by peritoneal dialysis. The compounds studied were derived from these dialysis fluids. Usually, 20 to 40 liters were taken from the first 100-liter bath used for dialysis. The fluid was concentrated in vacuo, acidified and extracted with butanol to obtain the acid fraction. It was then subjected to fractionation in a 20or 100-tube counter-current distribution apparatus8 using water and isobutanol as the solvents. The contents of each tube were titrated to pH 8 to determine the amount of acids present and then chromatographed on Whatman #1 paper in various solvent systems.
Fractions were eluted from the paper after fluorescing and absorbing bands were identified on the chromatograms. Details of the purification procedure are given in earlier papers."'0
The amino-acid-incorporating system designated by Sokoloff and Kaufmann as procedure A was modified slightly and used in these studies. Cell-free rat liver homogenates were prepared as described by Sokoloff and Kaufmann.' The incubation medium contained 75 psmol. of sucrose, 0.5 umol. of adenosine monophosphate, 10 ,umol. of tris (hydroxymethyl) aminomethane buffer (pH 7.4), 2.5 ,umol. MgCl2, 25 ,mol. a-ketoglutarate and 5 ,ucuries of DL 3H leucine (specific activity 5,000 ,c/ jumol.). Each reaction flash contained 0.25 ml. of liver homogenate. The samples dissolved in water or controls (which consisted of water only) were added to bring the reaction to a final volume of 0.85 ml. The reaction mixtures were shaken in 20 ml. penicillin bottles for 30 minutes at 370 C. in a water bath.
Incorporation of 3H leucine was measured by the "disc" method devised by Mans and Novelli.' A 0.1 ml. aliquot of reaction mixture was pipetted onto a 2.5 cm. disc of Whatman #3MM filter paper. After the protein solution was absorbed into the filter paper, the disc was plunged into ice cold 10 per cent trichloroacetic acid (TCA) containing 0.1M 12C DL leucine as carrier. In this wash and in all subsequent washes approximately 5 ml. of solution were used for every disc. All discs from each experiment were washed in batches. Discs were allowed to remain in contact with the carrier leucine for at least one hour. The batch of discs was then washed in 5 per cent TCA for 15 minutes at room temperature. They were then washed in 5 per cent TCA at 90°C. for 30 minutes and again in 5 per cent TCA at room temperature for 15 minutes. Further washing was accomplished by placing the discs in a solution made from equal volumes of diethyl ether and ethyl alcohol at 37°C. for 30 minutes. This wash was repeated. Finally, the batch was washed three times in ether to remove the remaining alcohol and water. The filter paper discs were dried overnight at room temperature. The isotope on the discs was counted directly in a liquid scintillation counter (Packard Tricarb Model 314E or Nuclear-Chicago Model 720) using 5 ml. of 1 per cent 2,5-diphenyloxazole (PPO) and 0.4 per cent p-bis[2-(5-phenyloxazolyl) ]benzene (POPOP). Sufficient counts were taken to obtain a counting error of less than three per cent. Three control discs were run concurrently with each experiment. The net counts obtained from the controls varied from 500 to 700 counts per minute. The controls in any one experiment agreed within five per cent. The data are expressed as per cent of the controls run concurrently in each experiment. 
EXPERIMENTAL RESULTS
In the first studies, five liters of dialysis fluid were concentrated, extracted, and processed by counter-current fractionation in a 20-tube instrument. Ten per cent of the dry residue of alternate tubes of the counter-current run was used for assay. The results are shown in Table 1 . The region of maximal inhibition was seen in tube 6, which would be equivalent to tube 30 in a 100-tube counter-current fractionation.
Material from tubes 4, 6, and 8 representing the area of the countercurrent fractionation that showed maximal suppression of uptake was titered to study the effects of decreasing amounts of fractions of dialysis fluid on amino acid incorporation into protein. The data are shown in Table 2 .
These data agree with the findings in Table 1 showing maximal inhibition in tube 6. At every comparable concentration, incorporation was lower in tube 6 than in tubes 4 or 8. Incorporation was lowest when fractions were in greatest concentration. Subsequent studies were performed on material 27s from this region of the counter-current fractionation. In an effort to separate the compounds present in this area, 16 per cent of the contents of tube 6 was placed on chromatographic paper (Whatman #1) and developed in an isopropanol-ammonia system, dried and redeveloped in the same solvent. Eleven equal segments were cut from this paper, eluted, dried and reconstituted with water. All the material was assayed as above. The results in Table 3 show that maximal decrease in amino acid incorporation was observed in the region of Rf 0.36 to 0.54. Every bioassay performed had a water control. In this experiment if the control value was inadvertently too low, the base line for comparison of amino acid uptake should be drawn higher than 100 per cent. However, the possible presence of stimulating factors cannot be excluded. Table 3 expresses relative uptake caused by fractions from a single chromatogram (double pass of solvents). These data are valuable in demonstrating the area of the chromatogram where inhibition occurs. The difference in amounts used, differences in fractionation and vagaries of bioassay explain the differences between the data in Tables 1 and 3 . However, demonstration of inhibition was apparent in every experiment.
In order to obtain more material of greater purity, 21 liters of dialysate were extracted and fractionated in a 100-tube counter-current apparatus. Tube 30 of this fractionation is comparable to tube 6 of a 20-tube countercurrent fractionation. A chromatogram (single pass) containing 10 per cent of the contents of tube 30 was cut into five equal bands. The results seen in Table 4 show the presence of inhibitory material at Rf 0.0 to 0.4. The higher Rf of active material in Table 3 is the result of a double pass on the chromatogram. The chromatograms of counter-current tubes close to tube 30 were studied further in order to determine which compounds were responsible for inhibiting the incorporation of 3H leucine. Several strongly absorbing bands on the chromatograms were observed in ultraviolet light. These were sharpened by multiple passes in the isopropanol solvent system, and the compounds were further isolated by using other solvent systems.
The major components isolated in this region were lactic acid and N-methyl-2-pyridone-5-carboxamide (2-PY amide). When 2-PY amide was tested at concentrations of 2 x 10-8 moles per liter, no inhibition was noted. This concentration of 2-PY amide was greater than that which had been tested from the paper chromatograms. Similarly, lactic acid did not inhibit protein synthesis at 1 x 10-1 molar concentration. This level was also greater than the amount tested from the chromatograms. Since these compounds in chemically pure form did not inhibit the system, it was assumed that they were not responsible for the effects observed when material from the chromatograms was tested. Subsequently, an ultraviolet absorbing compound from the same region of the chromatogram was isolated and found to be N-methyl-2-pyridone-5-formamidoacetic acid (2-PY hippurate)." When this compound was synthesized in our laboratory and tested, it was found to inhibit at 1 x 10-4 molar concentration. The amount of 2-PY hippurate present appeared to account for the inhibition found in paper chromatogram fractions. We found 2-PY hippurate in four patients. The pure compound isolated by counter-current fractionation and several runs on chromatograms was quantified by its ultraviolet absorbance. The amount of 2-PY hippurate quantified in four dialysates ranged from 4.2 to 86 ,ug/L. It was estimated (by assuming that half the 2-PY hippurate in the uremic patient appeared in the dialysis fluid and that the compound was uniformly distributed in body water) that these four uremic patients might have from 2 to 41 jug of 2-PY hippurate in 100 ml. of blood.'3 Another compound with a similar ultraviolet absorption spectrum was found in tube 61, a less polar region of the counter-current distribution, and identified as N-methyl-2-pyridone-5-carboxylic acid (2-PY acid).' lhis compound was found in the dialysate from one patient. Synthetic 2-PY acid also inhibited protein synthesis at 1 x 10-4 molar concentration. Normal plasma, cerebrospinal fluid and hemodialysate from a barbiturate poisoning (with normal kidneys) showed no 2-PY acid or 2-PY hippurate.
The effects of the three compounds were studied in two separate experiments at four different concentrations. The data, seen in Table 5 , show that 2-PY acid and 2-PY hippurate strongly inhibited protein synthesis. The other compound, 2-PY amide, appeared to stimulate uptake at some of the levels tested. These compounds, 2-PY amide, 2-PY acid, and 2-PY hippurate (see Fig. 1 ), have similar ultraviolet absorption characteristics. The spectrum Several other pure compounds known to be present in dialysis fluid were studied. The results with some of these are shown in Table 6 . These organic acids were not inhibitory at the concentrations studied.
DISCUSSION
Clinical improvement usually results from the treatment of uremic patients either with the artificial kidney or with peritoneal dialysis. This suggests that the small molecules which are removed by dialysis contribute to the symptomatology in uremia. Various research workers4' have shown that metabolic processes are impaired by factors present in the serum of an in vitro amino acid incorporation system, is impaired by crude fractions isolated from uremic dialysis fluid. It was possible to extend these observations to specific organic compounds, present in dialysis fluid, that decreased the incorporation of 3H leucine into liver homogenates. Two compounds, pure 2-PY hippurate and 2-PY acid, isolated from dialysis fluid, inhibited the system. Another related metabolite of nicotinic acid, 2-PY amide, did not inhibit protein synthesis at equimolar concentrations. Minor alterations of chemical structure profoundly affect the assay system used.
It is difficult to correlate findings obtained in vitro using cell-free systems with the complex deranged metabolism of a chronic disease such as uremia. It has been shown, however, that small organic anions similar to those studied are capable of entering human erythrocytes." Presumably, they can enter other cells.
The concentration of 2-PY hippurate observed to inhibit protein synthesis in the assay system was about 50 to 100 times the concentration estimated to be present in the body fluids of four patients. If it is noxious in zivo, sufficient time exists during the uremic syndrome for diffusion into cells where it could perhaps exert a similar effect to the in vitro one. If it exerts a deleterious effect, it could be because (1) it concentrates intracellularly, (2) it works over a long period of time (one to three weeks or more), or (3) it has an additive or synergistic effect with other compounds that accumulate in uremia. Although protein synthesis was used as a bioassay for adverse effects of 2-PY hippurate, in vivo metabolic consequences from it might be difficult to discern. SUMMARY An in vitro assay system which measures the incorporation of 3H leucine into protein has been used to demonstrate that fractions of dialysis fluid from uremic patients inhibit amino acid incorporation into protein. By analyzing consecutively the areas that showed greatest inhibition of incorporation, 2-PY hippurate was isolated and identified. This compound and another, 2-PY acid, found in a uremic patient, strongly inhibited the system. Another closely related compound, 2-PY amide, which traveled in a similar manner to 2-PY hippurate, did not affect the system. This assay may be of value in determining the toxic components present in uremia.
